← Browse by Condition
Medical Condition

advanced or metastatic kras mutant tumor in non small cell lung cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07148128 Phase 1, Phase 2
Recruiting

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Enrollment
110 pts
Location
United States, Canad...
Sponsor
Auricula Biosciences Inc.
View Trial →